These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 12817090)

  • 1. Pathogenesis of bone and cartilage destruction in rheumatoid arthritis.
    Goldring SR
    Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii11-6. PubMed ID: 12817090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone and joint destruction in rheumatoid arthritis: what is really happening?
    Goldring SR
    J Rheumatol Suppl; 2002 Sep; 65():44-8. PubMed ID: 12236623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synovial fluid macrophages are capable of osteoclast formation and resorption.
    Adamopoulos IE; Sabokbar A; Wordsworth BP; Carr A; Ferguson DJ; Athanasou NA
    J Pathol; 2006 Jan; 208(1):35-43. PubMed ID: 16278818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Destruction of articular cartilage].
    Koike T
    Clin Calcium; 2006 Sep; 16(9):1543-47. PubMed ID: 16951481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
    Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T
    Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model of inflammatory arthritis highlights a role for oncostatin M in pro-inflammatory cytokine-induced bone destruction via RANK/RANKL.
    Hui W; Cawston TE; Richards CD; Rowan AD
    Arthritis Res Ther; 2005; 7(1):R57-64. PubMed ID: 15642143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of interleukin-1 in bone resorption in rheumatoid arthritis.
    Strand V; Kavanaugh AF
    Rheumatology (Oxford); 2004 Jun; 43 Suppl 3():iii10-iii16. PubMed ID: 15150427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of osteoclast differentiation from macrophages: possible roles of T lymphocytes in osteoclastogenesis.
    Udagawa N
    J Bone Miner Metab; 2003; 21(6):337-43. PubMed ID: 14586789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
    Dai SM; Nishioka K; Yudoh K
    Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of cytokines and growth factors in rheumatoid joint destruction].
    Alsalameh S; Kalden JR; Burmester GR
    Z Rheumatol; 1991; 50(6):347-59. PubMed ID: 1796655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cytokines in the pathogenesis of rheumatoid arthritis.
    Feldmann M; Maini RN
    Rheumatology (Oxford); 1999 Nov; 38 Suppl 2():3-7. PubMed ID: 10646481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis.
    Dayer JM
    Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii3-10. PubMed ID: 12817089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis.
    Edwards JR; Sun SG; Locklin R; Shipman CM; Adamopoulos IE; Athanasou NA; Sabokbar A
    Arthritis Rheum; 2006 May; 54(5):1451-62. PubMed ID: 16649193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.
    Kobayashi M; Squires GR; Mousa A; Tanzer M; Zukor DJ; Antoniou J; Feige U; Poole AR
    Arthritis Rheum; 2005 Jan; 52(1):128-35. PubMed ID: 15641080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of cytokines and growth factors in joint destruction processes].
    Alsalameh S; Jerez R; Bujía J; Haeupl T; Kalden JR; Burmester GR
    Rev Med Chil; 1992 Dec; 120(12):1400-10. PubMed ID: 1343382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone loss in inflammatory arthritis: mechanisms and therapeutic approaches with bisphosphonates.
    Romas E
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):1065-79. PubMed ID: 16301197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular mechanisms of bone destruction in rheumatoid arthritis].
    Nanki T
    Clin Calcium; 2007 Apr; 17(4):510-6. PubMed ID: 17404479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of cell-substrate interaction in regulating osteoclast activation: potential implications in targeting bone loss in rheumatoid arthritis.
    McHugh KP; Shen Z; Crotti TN; Flannery MR; O'Sullivan RP; Purdue PE; Goldring SR
    Ann Rheum Dis; 2010 Jan; 69 Suppl 1():i83-85. PubMed ID: 19995752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma inhibitory activity, a biomarker related to chondrocyte anabolism, is reversibly suppressed by proinflammatory cytokines in rheumatoid arthritis.
    Vandooren B; Cantaert T; van Lierop MJ; Bos E; De Rycke L; Veys EM; De Keyser F; Bresnihan B; Luyten FP; Verdonk PC; Tak PP; Boots AH; Baeten D
    Ann Rheum Dis; 2009 Jun; 68(6):1044-50. PubMed ID: 18633128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.